Welcome to our dedicated page for Carecloud news (Ticker: CCLDP), a resource for investors and traders seeking the latest updates and insights on Carecloud stock.
CareCloud, Inc. provides healthcare technology, AI-enabled revenue cycle management and related software for ambulatory and inpatient care settings. The company’s recurring updates cover revenue cycle management, practice management, electronic health records, business intelligence, patient experience management, emergency department information systems and digital health offerings, including platform developments such as MAP App and Marketware.
CareCloud announcements also include customer partnerships with medical practices, AI product introductions, conference and investor-event presentations, financial results, acquisitions and capital-structure actions. The CCLDP symbol is associated with CareCloud’s Series A Cumulative Redeemable Perpetual Preferred Stock, which the company has described as converted into common equity in 2025.
CareCloud (Nasdaq: CCLD, CCLDO) closed a $50 million credit facility on April 13, 2026, with Citizens Bank and Provident Bank and will fully redeem 100% of its outstanding 8.75% Series B preferred stock on May 15, 2026.
The redemption covers 1,511,372 shares at a Total Redemption Price of $27.52 per share, eliminates roughly $3.2 million in annual preferred dividends, and simplifies the capital structure while preserving non-dilutive institutional financing and liquidity.
CareCloud (Nasdaq: CCLD) announced a new partnership with Arkansas Otolaryngology Center to deploy AI-enabled practice management and revenue cycle management (RCM) solutions across the multi-location ENT practice.
The collaboration will deliver AI-powered claims management, automated denial prevention, coding education, real-time dashboards, and AI-driven financial analytics aimed at accelerating revenue capture and improving clean claim rates, with the company emphasizing reductions in days in accounts receivable and enhanced operational transparency.
CareCloud (Nasdaq: CCLD) will present at the 2026 AAPPR Annual Conference in Orlando, April 13–15, showcasing its Marketware physician strategy platform and a soon-to-launch AI update.
Marketware aims to improve pipeline visibility, accelerate time-to-fill, match clinical candidates to best-fit roles, and measure recruitment ROI. The presentation, “The Right Data, Right Now: Recruitment Reporting That Matters,” will highlight real-time pipeline visibility, actionable workforce strategy, and ROI from recruitment investments.
CareCloud (Nasdaq: CCLD) highlighted the completed Preferred A conversion and progress toward simplifying capital structure. The March 6, 2025 conversion issued ~26 million common shares, raising total common shares from ~16 million to ~42 million. The company reaffirmed prior financial guidance and cited recurring revenue and strong cash flow.
CareCloud noted a recent closing price of $3.49 (March 27, 2026) and said ~3 substantial Preferred A holders remain outstanding; ~ $40 million of Series B preferred remains non-convertible.
CareCloud (Nasdaq: CCLD) is showcasing its enhanced MAP App at the HFMA Revenue Cycle Conference in Arlington, March 19, 2026, demonstrating updates made since acquiring the platform from HFMA.
The company will host a networking happy hour on March 19 and a live webinar on April 7, 2026 at 1:00 PM ET to review product updates, roadmap, and use cases.
CareCloud (Nasdaq: CCLD) will participate in the 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum on March 17, 2026, featuring a company fireside chat streamed live to registered attendees.
CareCloud recently reported full-year 2025 results: its first full year of positive EPS since IPO, exceeded its upsized revenue forecast range, and increased free cash flow by more than 500% over three years. A replay will be available at the company investor relations site.
CareCloud (Nasdaq: CCLD) will ring the Nasdaq Closing Bell on May 19, 2026 and host its 2026 Analyst Day at the Nasdaq MarketSite in New York City. The event will showcase new AI-powered products and a management business update on strategic priorities.
The announcement highlights CareCloud reporting its first full year of positive EPS since its IPO 12 years ago and a roughly 18% rise in its common stock over two trading days after release of full-year 2025 results.
CareCloud (Nasdaq: CCLD) reported full‑year 2025 revenue of $120.5M (+8.7% YoY), GAAP net income of $10.8M (+37.5% YoY) and its first full‑year positive GAAP EPS since its 2014 IPO of $0.10. The company closed acquisitions including Medsphere, entered inpatient software, launched AI products, generated $28.6M cash from operations and repaid its credit line.
Management issued 2026 guidance: $128–$132M revenue, $29–$31M adjusted EBITDA and GAAP EPS of $0.20–$0.23.
CareCloud (Nasdaq: CCLD) will release fourth quarter and full year 2025 financial results before market open on March 12, 2026.
A conference call for investors will follow at 8:30 a.m. ET with a live webcast, audio options, downloadable slides, and a replay available at ir.carecloud.com/events.
CareCloud (Nasdaq: CCLD) announced a new contract with Memorial Hospital in Marysville, Ohio to deploy the HealthLine clinical supply chain platform. HealthLine, acquired via CareCloud's August 2025 purchase of Medsphere, aims to reduce supply waste, improve charge capture, and free clinicians from manual inventory tasks.
The platform delivers point-of-use scanning, automated charge capture, mobility, specialized modules for high-cost areas, and a modern architecture; CareCloud plans to add AI capabilities over coming quarters to boost efficiency and insights.